Computational biologist with interest in cancer biology and translational cancer research

2023/12/21

The Cancer Therapy Resistance Lab at CIC bioGUNE (Bilbao-Spain), led by Dr. Ana Ruiz-Saenz, strive to understand the molecular mechanisms underlying resistance to targeting therapies, with an especial focus on the role of tumor-associated aberrant glycosylation in breast cancer. Current and future projects are exploring new aspects of resistance to HER2-targeting therapies (antibodies, and antibody-drug conjugates) integrating clinical data, 3D cancer cell models, high-throughput approaches, CRISPR-Cas9 technology and co-culture systems.

The successful candidate will be in charge of project(s) involving analysis of newly generated data (NGS, transcriptomics) and publicly available clinical datasets (TCGA, Metabric…). The candidate should know how to evaluate and interpret research results independently; prepare them for submission to scientific journals and international meetings and write scientific abstracts and manuscripts. Specific projects will be discussed based on the candidate interest, competence, and projected scientific trajectory, with the possibility of participating in a project in collaboration with AstraZeneca.

Application procedure:

Highly motivated candidates please send CV, cover letter and contact of 3 references using our specified form and indicating form and indicating 42081 as reference.